- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.3: 1 residues within 4Å:- Chain A: N.144
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.144
- Water bridges: A:N.144
NAG.17: 1 residues within 4Å:- Chain B: N.144
No protein-ligand interaction detected (PLIP)NAG.29: 1 residues within 4Å:- Chain C: N.144
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:N.144
- Water bridges: C:N.144
NAG.43: 1 residues within 4Å:- Chain D: N.144
1 PLIP interactions:1 interactions with chain D- Water bridges: D:E.436
- 4 x CA: CALCIUM ION(Non-covalent)
CA.4: 5 residues within 4Å:- Chain A: D.293, T.297, D.324, G.344, G.346
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:D.293, A:T.297, A:D.324, A:G.344, A:G.346
CA.18: 5 residues within 4Å:- Chain B: D.293, T.297, D.324, G.344, G.346
6 PLIP interactions:5 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.293, B:T.297, B:D.324, B:G.344, B:G.346, H2O.20
CA.30: 5 residues within 4Å:- Chain C: D.293, T.297, D.324, G.344, G.346
5 PLIP interactions:5 interactions with chain C- Metal complexes: C:D.293, C:T.297, C:D.324, C:G.344, C:G.346
CA.44: 5 residues within 4Å:- Chain D: D.293, T.297, D.324, G.344, G.346
6 PLIP interactions:5 interactions with chain D, 1 Ligand-Water interactions- Metal complexes: D:D.293, D:T.297, D:D.324, D:G.344, D:G.346, H2O.43
- 40 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.5: 9 residues within 4Å:- Chain A: C.122, G.123, P.124, N.125, E.126, C.127, I.415, K.416
- Chain D: E.208
Ligand excluded by PLIPEDO.6: 4 residues within 4Å:- Chain A: P.88, E.419, C.420
- Chain D: R.260
Ligand excluded by PLIPEDO.7: 5 residues within 4Å:- Chain A: P.88, G.450
- Chain D: T.211, D.212, R.260
Ligand excluded by PLIPEDO.8: 8 residues within 4Å:- Chain A: R.102
- Chain D: H.134, Y.142, N.144, G.145, T.146, N.151, L.153
Ligand excluded by PLIPEDO.9: 7 residues within 4Å:- Chain A: Y.143, N.144, G.145, T.146, R.147, G.148, K.435
Ligand excluded by PLIPEDO.10: 8 residues within 4Å:- Chain A: H.134, Y.142, N.144, G.145, T.146, N.151, L.153
- Chain B: R.102
Ligand excluded by PLIPEDO.11: 5 residues within 4Å:- Chain A: D.149, R.150, W.177, R.223, E.226
Ligand excluded by PLIPEDO.12: 6 residues within 4Å:- Chain A: Y.217, E.250, C.251, R.252, F.266, P.267
Ligand excluded by PLIPEDO.13: 3 residues within 4Å:- Chain A: D.320, D.392, A.393
Ligand excluded by PLIPEDO.14: 3 residues within 4Å:- Chain A: K.371, T.372
- Ligands: EDO.15
Ligand excluded by PLIPEDO.15: 3 residues within 4Å:- Chain A: D.329, K.371
- Ligands: EDO.14
Ligand excluded by PLIPEDO.16: 2 residues within 4Å:- Chain A: G.385, D.386
Ligand excluded by PLIPEDO.19: 4 residues within 4Å:- Chain A: R.260
- Chain B: P.88, E.419, C.420
Ligand excluded by PLIPEDO.20: 9 residues within 4Å:- Chain A: E.208
- Chain B: C.122, G.123, P.124, N.125, E.126, C.127, I.415, K.416
Ligand excluded by PLIPEDO.21: 6 residues within 4Å:- Chain B: S.90, T.91, V.381, S.397, G.452, Q.453
Ligand excluded by PLIPEDO.22: 7 residues within 4Å:- Chain B: Y.143, N.144, G.145, T.146, R.147, G.148, K.435
Ligand excluded by PLIPEDO.23: 6 residues within 4Å:- Chain B: A.245, E.275, E.276, R.292, N.294
- Ligands: EDO.24
Ligand excluded by PLIPEDO.24: 4 residues within 4Å:- Chain B: D.149, R.150, W.177
- Ligands: EDO.23
Ligand excluded by PLIPEDO.25: 4 residues within 4Å:- Chain B: R.147, D.432, G.433, G.434
Ligand excluded by PLIPEDO.26: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPEDO.31: 9 residues within 4Å:- Chain B: E.208
- Chain C: C.122, G.123, P.124, N.125, E.126, C.127, I.415, K.416
Ligand excluded by PLIPEDO.32: 4 residues within 4Å:- Chain B: R.260
- Chain C: P.88, E.419, C.420
Ligand excluded by PLIPEDO.33: 5 residues within 4Å:- Chain B: T.211, D.212, R.260
- Chain C: P.88, G.450
Ligand excluded by PLIPEDO.34: 8 residues within 4Å:- Chain B: H.134, Y.142, N.144, G.145, T.146, N.151, L.153
- Chain C: R.102
Ligand excluded by PLIPEDO.35: 7 residues within 4Å:- Chain C: Y.143, N.144, G.145, T.146, R.147, G.148, K.435
Ligand excluded by PLIPEDO.36: 8 residues within 4Å:- Chain C: H.134, Y.142, N.144, G.145, T.146, N.151, L.153
- Chain D: R.102
Ligand excluded by PLIPEDO.37: 5 residues within 4Å:- Chain C: D.149, R.150, W.177, R.223, E.226
Ligand excluded by PLIPEDO.38: 6 residues within 4Å:- Chain C: Y.217, E.250, C.251, R.252, F.266, P.267
Ligand excluded by PLIPEDO.39: 3 residues within 4Å:- Chain C: D.320, D.392, A.393
Ligand excluded by PLIPEDO.40: 3 residues within 4Å:- Chain C: K.371, T.372
- Ligands: EDO.41
Ligand excluded by PLIPEDO.41: 3 residues within 4Å:- Chain C: D.329, K.371
- Ligands: EDO.40
Ligand excluded by PLIPEDO.42: 2 residues within 4Å:- Chain C: G.385, D.386
Ligand excluded by PLIPEDO.45: 4 residues within 4Å:- Chain C: R.260
- Chain D: P.88, E.419, C.420
Ligand excluded by PLIPEDO.46: 9 residues within 4Å:- Chain C: E.208
- Chain D: C.122, G.123, P.124, N.125, E.126, C.127, I.415, K.416
Ligand excluded by PLIPEDO.47: 6 residues within 4Å:- Chain D: S.90, T.91, V.381, S.397, G.452, Q.453
Ligand excluded by PLIPEDO.48: 7 residues within 4Å:- Chain D: Y.143, N.144, G.145, T.146, R.147, G.148, K.435
Ligand excluded by PLIPEDO.49: 6 residues within 4Å:- Chain D: A.245, E.275, E.276, R.292, N.294
- Ligands: EDO.50
Ligand excluded by PLIPEDO.50: 4 residues within 4Å:- Chain D: D.149, R.150, W.177
- Ligands: EDO.49
Ligand excluded by PLIPEDO.51: 4 residues within 4Å:- Chain D: R.147, D.432, G.433, G.434
Ligand excluded by PLIPEDO.52: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Escuret, V. et al., A Novel I221 L Substitution in Neuraminidase Confers High Level Resistance to Oseltamivir in Influenza B Viruses. J.Infect.Dis. (2014)
- Release Date
- 2014-05-14
- Peptides
- NEURAMINIDASE: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x CA: CALCIUM ION(Non-covalent)
- 40 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Escuret, V. et al., A Novel I221 L Substitution in Neuraminidase Confers High Level Resistance to Oseltamivir in Influenza B Viruses. J.Infect.Dis. (2014)
- Release Date
- 2014-05-14
- Peptides
- NEURAMINIDASE: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B